Objective. To investigate the validity and responsiveness of the World Health Organization Disability Schedule II (WHODAS II) in patients with established RA.
Introduction
Despite important advances in medical treatment, RA is a disease that has a major impact on multiple life areas. Therefore, in many patients, the institution of rehabilitative treatment strategies is required [1] . To optimize the rehabilitation process, a systematic evaluation of disability is needed [2] [3] [4] (Self-care),'getting along with others' (Interpersonal interactions and relationships), 'life activities' (Major life areas), 'participation in society' (Community, social and civic life). It also generates a general disability score. The WHODAS II was specifically developed to measure clinical outcomes and treatment effectiveness over time.
The psychometric properties of the WHODAS II have been tested rigorously by using the item response theory analysis and have been shown to be excellent [5] . The WHODAS II distinguishes from other measures of disability as it is based on an international classification system, it is applicable across cultures and it treats all disorders at parity when determining the level of functioning [6] .
With respect to rheumatology, earlier studies have shown the validity of the WHODAS II in patients with various musculo-skeletal disorders including AS [7] , back pain and mixed musculo-skeletal conditions [8] and SSc [9, 10] . Concerning RA, the WHODAS II proved to be valid and reliable in a cross-sectional study of patients with early inflammatory arthritis, of whom 19% met the ACR criteria for RA [6] . Pö sl et al. [8] found WHODAS II to be an acceptable outcome measure in patients with various musculo-skeletal diseases (including RA) undergoing rehabilitation. As in this study by Pö sl et al, the results were not presented separately per patient group; it remains unclear whether the WHODAS II is a suitable outcome measure in the rehabilitation of patients with RA. Therefore, the present study aimed to investigate the internal consistency, validity and responsiveness of the WHODAS II in patients with established RA participating in a multidisciplinary team care programme.
Subjects and methods

Subjects
Data were gathered as part of a larger prospective study, showing that the Rehabilitation Activities Profile, an ICFbased rehabilitation tool, can be successfully implemented in multidisciplinary team care and has a modest, positive effect to the satisfaction of patients and team members [11] [12] [13] [14] . For this study, patients were consecutively recruited at the inpatient and day-patient multidisciplinary team care wards of the Rheumatology Clinic of the Leiden University Medical Center. Inclusion criteria were: RA as defined by the 1987 ARA criteria [15] , being older than 18 years, sufficient physical and emotional status to take part in assessments and to complete questionnaires; the latter to be judged by the physician. For the present study, only the data of the 12-month period when the Rehabilitation Activities Profile was implemented were used. Patients who were willing to participate gave written informed consent according to the Declaration of Helsinki 1996. The study was approved by the ethical committee of the Leiden University Medical Center.
Multidisciplinary team care
All patients in both the inpatient and day-patient care wards were treated by a multidisciplinary team comprising a rheumatologist, an occupational therapist, a physical therapist, a social worker and nurses. Day patients and inpatients followed defined treatment programmes. Individual and group exercise therapies were fixed components of the programme, with individual occupational therapy and interventions by other medical specialists and health professionals scheduled according to individual needs.
Assessment methods
Clinical assessments were performed at admission (baseline), discharge and 6 weeks after discharge. For the present study, only the baseline data and the follow-up data 6 weeks after discharge were used because the WHODAS II was not administered at discharge. All clinical assessments were executed by one trained health professional (J.V.), who was not involved in the treatment.
Socio-demographic and disease characteristics
Socio-demographic and disease characteristics recorded at admission were age, sex, status of living, educational level (low: up to and including lower technical and vocational training; medium: up to and including secondary technical and vocational training; and high: up to and including higher technical and vocational training and university), employment status, disease duration, the presence of RF and erosions, current medication and previous admissions to the rehabilitation clinic.
Medical treatment
Data on the number of treatment days and the use of NSAIDs, DMARDs, oral corticosteroids (prednisone) and IA or intra-muscular injections with corticosteroids (yes/no) were gathered from the medical records.
WHODAS II
We used the self-administered 36-item version of the WHODAS II in Dutch [5, 16] . The WHODAS II consists of 36 items clustered into six subscales designed to assess health status. The number of items per subscale ranges between four and eight. The WHODAS II assesses difficulties with functioning and disability in each of the six subscales over the past 30 days. The 36 items of the WHODAS II are scored using a 5-point Likert scale ranging from '1 = none' to '5 = extreme/cannot do'. The subscale scores range from 0 (best) to 100 (worst).
The subscale scores and the final total score are calculated using the 36-item version if patients have a job or are in school and the 32-item version (where the four questions on work ability are omitted) if patients are not working [5] . Both total scores reflect the overall disability score and range from 0 (best) to 100 (worst).
Physical functioning
Physical functioning was measured according to the following instruments. . The 50-feet walk test, pertaining to the time needed to walk 50 feet (15.25 m) on a flat surface (seconds) [18] .
. The timed-stands test, where patients were asked to stand up and down from a sitting position 10 times as quickly as possible, without using their hands and keeping both feet on the floor (seconds) [19] .
. The stair test, pertaining to the time needed to go up and down a flight of 10 steps (seconds) [20] .
. Grip strength, measured using the Martin Vigorimeter (kPa). Each hand was measured three times, with the highest of three scores being used. The mean grip strength of the right and the left hands was calculated [21] .
. The Escola Paulista de Medicina Range of Motion scale (EPM-ROM), which measures the range of motion of 10 active assisted movements of selected joints with goniometry. The scale ranges from 0 (full joint flexibility) to 30 (severe limited joint flexibility) [22] .
Psychological functioning
Psychological functioning was measured with the psychological interaction scale (mood: 5 items; level of tension: 5 items) of the Dutch Arthritis Impact Measurement Scales-2 (D-AIMS2), with the scale score ranging from 0 to 10 and a higher score indicating a worse psychological health status [23] .
Disease activity
Disease activity was measured with the disease activity score-28 (DAS-28), a composite index including the number of swollen and tender joints, a visual analogue scale (VAS) for patients' global assessment of disease activity (VAS disease activity) and ESR.
The DAS-28 was calculated according to the formula: 0.56 (number of tender joints) + 0.28 (number of swollen joints) + 0.70 ln(ESR) + 0.014 (VAS patients' global assessment of disease activity) [24] . DAS-28 end-point scores <3.2 are considered to represent low disease activity, between 3.2 and 5.1 moderate disease activity and >5.1 high disease activity [25] . Pain was measured with a VAS consisting of a 100-mm horizontal line, ranging from 0 on the left anchor (no pain at all) to 100 on the right anchor (unbearable pain).
Quality of life
Quality of life (QoL) was measured with a Dutch version of the Rheumatoid Arthritis Quality of Life (RAQoL) questionnaire, comprising 30 'yes/no' questions. The total score ranges from 0 to 30, with a lower score indicating higher QoL [26] .
Statistical analysis
In case of non-normality, the data were log-transformed. The internal consistency of the WHODAS II total score and the six WHODAS II subscale scores was determined by calculating the Cronbach's-a according to the baseline data. The internal consistency is considered to be good when Cronbach's-a is between 0.70 and 0.95 [27] .
To investigate the relationship between the WHODAS II total score and socio-demographic and disease characteristics, WHODAS II scores were compared among categories of patients. For this purpose, continuous data were dichotomized according to the median and the unpaired t-test or analysis of variance was used, depending on the number of categories.
Possible floor or ceiling effects of the WHODAS II were determined by using the frequency distributions of the WHODAS II total and subscale scores at admission. Floor or ceiling effects are considered to be present if >15% of the respondents achieved the lowest or highest possible score, respectively [27] .
In this study, two aspects of construct validity were used: convergent validity (how strongly a measure correlates with other related measures) and discriminative validity (the ability to distinguish between 'known groups' with expected differences in scores) [27] . To test the convergent validity, correlations between the WHODAS II total score and its subscale scores on the one side and measures of physical and psychological functioning, disease activity and overall QoL on the other side were determined.
We hypothesized that higher WHODAS II total scores would be associated with worse physical and psychological functioning, higher levels of disease activity and a lower QoL. Furthermore, as WHODAS II total score is a measure of activities and participation, we hypothesized that correlations with general measures of physical functioning (HAQ) and overall QoL (RAQoL) would be the strongest, whereas correlations with measures addressing one aspect of physical functioning (50-feet walk test, timed-stands test, stair test, grip strength and EPM-ROM scale) would be weaker.
To test the discriminative validity of the WHODAS II total score, we calculated the WHODAS II total scores within four different categories (quartiles) of the HAQ scores at admission and compared them with each other using one-way analysis of variance, and for post-hoc multiple comparisons using Bonferroni correction.
For all outcome measures, mean differences (and S.D.s) between admission and 6 weeks after discharge were calculated with 95% CIs, with their P-values derived from the paired-sample t-test. The magnitude of change of all measures was described by the standardized response mean (SRM; mean score at admission minus the mean score at 6 weeks after discharge divided by the S.D. of the change score) [28] , the effect size (ES; mean score at admission minus the mean score at 6 weeks after discharge divided by the S.D. of the mean score at admission) and the responsiveness ratio (RR; the mean change score of 'improved' patients divided by the S.D. of the change score in 'stable' patients) [29] . For calculating the RR, the distinction between improved and stable patients was made on the basis of the HAQ score, where a difference of 50.19 is considered to be clinically significant [30] . Patients with an improvement of the HAQ score 50.19 were classified as improved, HAQ change scores between À0.19 and 0.19 as stable and an HAQ change score À0.19 or less as deteriorated. The interpretation of the magnitude of the ES can also be applied to the SRM and RR, with 0.2 being considered as low, 0.5 as moderate and 0.8 as high, independent of the sign [30, 31] .
All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS 15.0 for Windows, Chicago, IL, USA), with P 4 0.05 is considered to be statistically significant. Tests were all two-sided.
Results
The socio-demographic and clinical characteristics of the 85 patients included in the study are shown in Table 1 . Two (4%) patients had a dose or application change with NSAIDs, 28 (36%) patients with DMARDs and 5 (23%) with prednisone. Eleven (21%) patients started new NSAIDs, 22 (28%) started new DMARDs and 7 (32%) started prednisone. All other patients were maintained at stable dosage of medication.
At baseline, the minimum score (0) of the WHODAS II total score was not found. The numbers (proportions) of patients with a minimum score for the subscales were 12 (17%) for the subscale 'understanding and communicating', 0 for 'getting around', 10 (14%) for 'self-care', 13 (18%) for 'getting along with people', 0 for 'life activities' and 0 for 'participation in society', respectively. In none of the patients was the maximum score reached for the WHODAS II total score or the subscale scores.
With respect to the internal consistency of the WHODAS II, in the 64 (75%) patients who did not work or go to school, Cronbach's-a was 0.89 for the total score and 0.84 for the subscale 'life activities'. In the 21 (25%) patients attending either work or school, the Cronbach's-a of the WHODAS II was 0.93 for the total score and 0.90 for 'life activities'. The Cronbach-a for the composite scores (working and non-working combined) was 0.91 for the total score, 0.87 for the subscale 'understanding and communicating', 0.65 for the subscale 'getting around', 0.79 for the subscale 'self-care', 0.73 for the subscale 'getting along with people', 0.90 for the subscale 'life activities' and 0.75 for the subscale 'participation in society', respectively.
Overall, there were no associations between the WHODAS II total score and socio-demographic characteristics or the presence of RF, erosions and the usage of medication (results not shown), apart from a significantly higher WHODAS II total score in patients who had a low education level (41.9, S.D. 13.8) as compared with patients who had a medium education level (44.4, S.D. 16.1) or a high education level (29.4, S.D. 15.9) (Kruskal-Wallis test: chi-square 7.1; df = 2; P = 0.028). Table 2 shows the baseline values of measures of functional status, psychological functioning, disease activity and QoL and their associations with the WHODAS II total score. All data were normally distributed, except for the results of the 50-feet walk test, timed-stands test, stair test and grip strength at admission, so these data were log-transformed.
In general, significant associations were found between the WHODAS II and all other measures except for the 50-feet walk test, timed-stands test and EPM-ROM. The correlations indicated that higher WHODAS II scores were associated with worse physical and psychological functioning, higher levels of disease activity and lower QoL.
The discriminating properties of the WHODAS II, reflected by the WHODAS II total score within four different categories of the HAQ, showed that the WHODAS II total score increased with higher HAQ scores. The mean WHODAS II scores were 31.4 (S.D. 11.2), 35.6 (S.D. 13.7), 40.7 (S.D. 11.5) and 53.0 (S.D. 14.2) in the first, second, third and fourth quartiles, respectively. The differences seen in the WHODAS II total scores between the first and the fourth (P < 0.001), the second and the fourth (P < 0.001) and the third and the fourth (P = 0.038) HAQ quartiles reached statistical significance; all P-values were Bonferroni corrected. Table 3 shows the baseline scores, the change scores and the responsiveness scores of the various outcome measures. At admission, the mean WHODAS II total score was 40.5 (S.D. 14.9). The mean WHODAS II total score for the working and the non-working groups were, respectively, 36.8 (S.D. 16.1) and 41.5 (S.D. 14.5; P = 0.30).
The mean WHODAS II total score and the subscale scores 'getting around' and 'participation in society' improved significantly between admission and 6 weeks after discharge, whereas the changes in the subscales 'understanding and communicating', 'self-care', 'getting along with people' and 'life activities' did not reach statistical significance. With respect to the other outcome measures, significant improvements were seen for all outcome measures, except for the EPM-ROM and VAS-Pain.
Six weeks after discharge, the numbers of patients classified as improved, stable or deteriorated according to the HAQ were 32 (45%), 28 (39%) and 11 (16%), respectively. The change scores of the WHODAS II total score in these three categories [i.e. 6.4 (S.D. 15.1; P = 0.04), 5.4 (S.D. 11.0; P = 0.027) and À3.2 (S.D. 9.6; P = 0.42)] were used to calculate the RR.
The responsiveness of the WHODAS II total score was low to moderate, with the values for SRM, ES and RR being, respectively, À0.35, À0.34 and À0.58 at 6 weeks after discharge. The responsiveness of the six subscales was, in general, smaller than that of the WHODAS II total score, except for the subscales 'getting around' and 'participation in society', which both scored higher on all three responsive measures.
Discussion
This study in a rheumatology rehabilitation setting demonstrated that the self-administered WHODAS II is an internally consistent and valid tool to assess disability in patients with established RA admitted for multidisciplinary team care.
In this patient group, the internal consistency determined by Cronbach's-a was good in both the working as well as the non-working groups for the WHODAS II total score [27] and for its subscales, except for the 'getting around subscale', with the results being in the same range as those obtained in previous studies with other patient groups [6, 8] .
The responsiveness of the WHODAS II total disability score was low to moderate, but nevertheless in the same range as that of established, disease-specific outcome measures such as the HAQ and RAQoL. Only the timed-stands test consistently demonstrated higher responsiveness compared with the WHODAS II total score for all three measures of responsiveness.
For the subscales that are particularly relevant for patients with RA (i.e. 'getting around' and 'participation in society'), the responsiveness scores were found to be high, with the RR being 0.84 and 0.80, respectively. The high responsiveness in the participation domain is interesting, especially given the relatively short time frame of the intervention and follow-up. Currently, very few outcome measures comprise the ICF participation domain. Recently, Li et al. [32] developed and validated the Activity Participation Questionnaire (APaQ) as a simple measure of activity participation for patients with RA. The results of their study, executed in patients with variable disease duration, showed similar responsiveness scores as the WHODAS II subscale 'participation in society' [32] .
The average WHODAS II total score of 40.5 at baseline found in the present study was higher than the median score of 19.8 found in patients with early inflammatory arthritis [6] , the mean score of 23.9 in a population of patients with AS partially undergoing spa treatment [7] , the mean score of 24.6 in SSc [10] and a mean score of 19.8 in a population with various musculoskeletal disorders undergoing rehabilitation [8] . However, the high WHODAS II total scores can be explained by our selection of patients with established RA who were admitted for multidisciplinary team care and, on average, had a high disease activity (DAS-28 5.46).
Our study shows the greatest problems in functioning in the subscales 'life activities' (60.6, S.D. 26.5), 'getting around' (55.5, S.D. 20.5) and 'participation in society' (43.3, S.D. 18.9). Exactly the same rank order was found in other studies concerning the use of the WHODAS II in rheumatic diseases [6] [7] [8] 10] .
We found a significant floor effect within the subscales 'understanding and communicating' and 'getting along with people' and a borderline floor effect within the subscale 'self-care'. Similar floor effects have been reported in these subscales in earlier studies on the WHODAS II [8] and another ICF-based outcome measure Scores were log-transformed due to non-normality. *The correlation is significant at the 0.05 level (two-tailed). **The correlation is significant at the 0.01 level (two-tailed).
(the Rehabilitation Activities Profile) [13] . It is conceivable that these floor effects could have had a negative impact on the content validity, reliability and responsiveness of these subscales as well as the WHODAS II total score [27] .
Moderate, yet significant, associations are found between the WHODAS II total score and measures of overall physical (HAQ) and psychological functioning (D-AIMS2) and health-related QoL (RAQoL). Compared with the associations between the SF-36 and the WHODAS II described by van Tubergen et al. [7] , our associations are slightly weaker. In general, our hypotheses stand: worse scores on the WHODAS II are associated with lower QoL, worse physical and psychological functioning and high disease activity. Thereby, the associations between the WHODAS II and measures addressing one aspect of physical functioning (50-feet walk test, timed-stands test, stair test, grip strength and EPM-ROM scale) are the weakest. Our confirmed hypotheses, combined with the discriminating properties of the WHODAS II regarding four categories (quartiles) of the HAQ score substantiate its validity in patients with RA.
A limitation of this study is the fact that neither the patient nor the assessor was blinded. This absence of control could have introduced bias towards improvement. In this respect, the inclusion of a control group without treatment could have enhanced the contrast between stable vs improved patients. Moreover, the study was executed in one rheumatology clinic, so that the results may not be generalized to all patients with RA admitted for multidisciplinary team care. In our study, we cannot draw conclusions on reproducibility because the WHODAS was not administered twice in a period in which the sample is expected to be stable. However, no problems in reproducibility are expected, since the study by Baron et al. [6] produced excellent results for reproducibility in both the working and non-working groups, as well as for all subscale scores.
Because the sample size was relatively small and multiple comparisons were performed on it, the risk of Scores were log-transformed due to non-normality. *The level of significance was set at P < 0.05. SRM, ES and RR: 0.2, small effect; 0.5, moderate effect; and 0.8, large effect. NA: not applicable.
www.rheumatology.oxfordjournals.org non-reproducibility of our results in other samples increases. The authors, however, intentionally limited the time frame and the rehabilitation setting to optimize control over the contents of the intervention as well as minimizing the risk of major medical advancements influencing the outcomes.
The WHODAS II does not comprise personal factors such as patient perception, which play an important role in self-management strategies [33] . In addition, the WHODAS II does not take into account environmental factors, which may have a considerable impact on limitations in activities and societal participation. For clinical use in a multidisciplinary setting, using an outcome measure to enhance insight into personal and environmental factors in addition to the WHODAS II seems useful. Moreover, the WHODAS II does not comprise all elements found to be relevant in RA as represented by the ICF core set for RA [34] .
In conclusion, the WHODAS II appears to be an internally consistent, valid, responsive and usable outcome measure with good discriminating properties to assess disability in patients with RA admitted for multidisciplinary team care. The responsiveness to change of the WHODAS II is in line with other outcome measures to assess physical functioning and relatively outstands in the subscales 'getting around' and 'participation in society'. The WHODAS II as a health-related QoL instrument is unique in combining self-administration, conceptual compatibility to the ICF and its capability to describe the consequences of disease on one's participation in society. Therefore, the WHODAS II can be used in clinical and research settings to evaluate individuals with RA as well as groups of patients with RA in terms of ICF. Further research is needed to compare the relevance and practical applicability of the WHODAS II with other ICF-based rehabilitation tools.
Rheumatology key messages
. WHODAS II is a usable tool to assess disability in team care for RA patients. . In multidisciplinary team care, adding outcome measures to assess personal and environmental factors is recommended.
